Author

S. Poehlmann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Organism:mouse· 3 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Organism:human· 1

Frequent Co-Authors

M. Hoffmann· 3 shared H. Jacobsen· 2 shared K. Metzdorf· 2 shared L. Cicin-Sain· 2 shared M. Widera· 2 shared S. Ciesek· 2 shared A. Bloetz· 1 shared A. Cara· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

M. Hoffmann

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

TMPRSS2 is essential for SARS-CoV-2 Beta and Omicron infection

K. Metzdorf, H. Jacobsen, M. C. Greweling-Pils, M. Hoffmann, T. Lueddecke, F. Miller, L. Melcher, A. M. Kempf, I. Nehlmeier, D. Bruder, M. Widera, S. Ciesek, S. Poehlmann, L. Cicin-Sain

The paper shows TMPRSS2 is essential for SARS-CoV-2 Beta and Omicron infection in mice, highlighting its role as an antiviral target.

bioRxiv · Dec 9, 2022Immunology

A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants

K. Metzdorf, H. Jacobsen, Y. Kim, L. G. Teixeira Alves, U. Kulkarni, K. Eschke, M. Z. Chaudhry, M. Hoffmann, F. Bertoglio, M. Ruschig, M. Hust, M. C. Brdovcak, J. Materljan, M. Sustic, A. Krmpotic, , L. Cicin-Sain

A single dose of a recombinant murine CMV vaccine expressing SARS-CoV-2 spike protein provides long-lasting immunity against multiple variants in mice.

bioRxiv · Nov 25, 2022Immunology

Protective mucosal immunity against SARS-CoV-2 after heterologous systemic RNA-mucosal adenoviral vector immunization

D. Lapuente, J. Fuchs, J. Willar, A. V. Antao, V. Everlein, N. Uhlig, L. Issmail, A. Schmidt, F. Oltmanns, A. S. Peter, S. Mueller-Schmucker, P. Irrgang, K. Fraedrich, A. Cara, M. Hoffmann, , M. Tenbusch

This study shows that intranasal adenoviral vector boosts after mRNA priming enhance mucosal immunity and protection against SARS-CoV-2 in mice.

bioRxiv · Aug 3, 2021Immunology

Natural Cystatin C fragments inhibit GPR15-mediated HIV and SIV infection without interfering with GPR15L signaling

M. Hayn, A. Bloetz, A. Rodriguez-Alfonso, S. Vidal, N. Preising, L. Staendker, S. Wiese, C. M. Stuerzel, M. Harms, R. Gross, C. Jung, M. Kiene, B. H. Hahn, T. Jacob, S. Poehlmann, , F. Kirchhoff

The paper identifies a Cystatin C fragment that inhibits GPR15-mediated HIV and SIV infection without affecting GPR15L signaling.

bioRxiv · Oct 26, 2020Microbiology